Advertisement · 728 × 90
#
Hashtag
#migrainepatients
Advertisement · 728 × 90
Preview
Lundbeck unveils migraine data for eptinezumab at international congress - PharmaTimes New phase 4 results show sustained symptom relief and improved patient outcomes

#neurology #drugdevelopment #Lundbeck #migraine #eptinezumab #migarinesymptomrelief #patientoutcomes #InternationalHeadacheCongress #migrainepatients #chronicmigraine #RESOLUTIONclinicaltrial #SUNSETclinicaltrial #medicationoveruseheadache #monthlymigrainedays #MMDs
zurl.co/LE6FP

1 0 0 0
Preview
Lundbeck unveils migraine data for eptinezumab at international congress - PharmaTimes New phase 4 results show sustained symptom relief and improved patient outcomes

#neurology #drugdevelopment #Lundbeck #migraine #eptinezumab #migarinesymptomrelief #patientoutcomes #InternationalHeadacheCongress #migrainepatients #chronicmigraine #RESOLUTIONclinicaltrial #SUNSETclinicaltrial #medicationoveruseheadache #monthlymigrainedays #MMDs
zurl.co/HStkM

0 0 0 0
Preview
FDA approves Click’s digital therapeutic for episodic migraine - PharmaTimes More than 37 million adults in the US are affected by migraine

#ClickTherapeutics #digitaltherapeutics #softwareenhanceddrugs #episodicmigraine #migraine #CT132 #preventionofepisodicmigraine #migraineprevention #migrainepatients #ReMMiDclincialtrial #migrainedays #ReMMiDCbridgingstudy #calcitoningenerelatedpeptideinhibitors
pharmatimes.com/news/fda-app...

0 0 0 0